{"data":{"event":{"id":"ca036c71-9172-40fd-8adc-c2355e9133e0","slug":"hariboss-an-integrated-platform-for-rna-targeted-drug-design-a264738e27","title":"\n\nHARIBOSS++: An Integrated Platform for RNA-Targeted Drug Design \n\n","short_summary":"Targeting RNA with small molecules is increasingly viewed as a pivotal strategy for future therapeutics. A major limitation in studying RNA-small molecule (RNA-SM) interactions is the lack of available experimental structures. HARIBOSS established a milestone as a curated database of RNA-SM complexes derived from the Protein Data Bank. Building on its community engagement, we present HARIBOSS++, an updated and next-generation platform designed to facilitate the study of future RNA-targeted drugs. Major updates include an extension of the pocketome to encompass binding sites where small molecul","full_description":"Targeting RNA with small molecules is increasingly viewed as a pivotal strategy for future therapeutics. A major limitation in studying RNA-small molecule (RNA-SM) interactions is the lack of available experimental structures. HARIBOSS established a milestone as a curated database of RNA-SM complexes derived from the Protein Data Bank. Building on its community engagement, we present HARIBOSS++, an updated and next-generation platform designed to facilitate the study of future RNA-targeted drugs. Major updates include an extension of the pocketome to encompass binding sites where small molecules interact not only with RNA but also with other biomolecules, enhanced analysis of RNA molecules by family, detailed 3D structural characterization, improved analysis of ligands chemical space, addition of experimental binding affinity as well as molecular dynamics data, when available. HARIBOSS++ opens new avenues for biologists, bioinformaticians, and machine learning researchers to investigate RNA-SM interactions on a new scale. HARIBOSS++ can be explored using a web interface freely available at https://hariboss.pasteur.cloud.","ledger_type":"benefit","primary_domain_id":"8f1af1b9-7302-4b51-aae9-fdfac04d158a","event_status":"provisional","event_date":"2026-09-13T00:00:00.000Z","discovery_date":"2026-09-13T00:00:00.000Z","first_published_date":"2026-09-13T00:00:00.000Z","last_reviewed_date":"2026-09-13T00:00:00.000Z","geographic_scope":"International","affected_population":null,"base_impact_tier":1,"base_score":"1.00","attribution_multiplier":"0.1000","evidence_multiplier":"0.1000","realization_multiplier":"0.2000","durability_multiplier":"0.5000","current_event_score":"0.001000","confidence_level":"low","score_explanation":"Auto-published from news ingest as a provisional placeholder. Score is conservative until a named release is identified and the record is rescored.","methodology_version_id":"d7881163-fb23-4e71-8625-bac1a8662c0f","original_methodology_version_id":"d7881163-fb23-4e71-8625-bac1a8662c0f","published_at":"2026-09-14T05:00:49.221Z","created_at":"2026-09-14T05:00:49.221Z","updated_at":"2026-09-14T05:00:49.221Z","flags":[],"domain_name":"Biology","domain_slug":"biology","methodology_version":"0.1"},"contributions":[{"id":"0047d742-b3d1-4e0d-bf6e-e179f98b9b63","event_id":"ca036c71-9172-40fd-8adc-c2355e9133e0","model_id":"535014f7-c941-4d39-aa9b-8f9c1d3d07b7","role_description":"Unspecified system mentioned or implied by a news item. Remap to a named release when identified.","attribution_multiplier":"0.1000","credit_share":"1.0000","contribution_score":"0.001000","attribution_rationale":"News ingest does not infer a named model from the publisher alone. Attribution stays unspecified until a release is identified.","attribution_confidence":"medium","first_used_date":"2026-09-13T00:00:00.000Z","model_version_if_known":null,"review_status":"approved","created_at":"2026-09-14T05:00:49.231Z","model_slug":"unspecified-ai-system","model_name":"Unspecified AI system","identity_class":"unknown","is_internal":false,"family_name":"Unspecified","family_slug":"unknown-unspecified","organization_name":"Unknown","organization_slug":"unknown"}],"sources":[{"id":"3ccd0496-917a-4791-bc52-b2f0b0c3f891","event_id":"ca036c71-9172-40fd-8adc-c2355e9133e0","url":"\nhttps://www.biorxiv.org/content/10.64898/2026.09.07.749797v1?rss=1\n","canonical_url":"\nhttps://www.biorxiv.org/content/10.64898/2026.09.07.749797v1?rss=1\n","source_type":"preprint","publisher":"bioRxiv","author":null,"publication_date":"2026-09-13T00:00:00.000Z","retrieved_at":"2026-09-14T05:00:49.239Z","title":"\n\nHARIBOSS++: An Integrated Platform for RNA-Targeted Drug Design \n\n","excerpt":"Targeting RNA with small molecules is increasingly viewed as a pivotal strategy for future therapeutics. A major limitation in studying RNA-small molecule (RNA-SM) interactions is the lack of available experimental structures. HARIBOSS established a milestone as a curated database of RNA-SM complexes derived from the Protein Data Bank. Building on its community engagement, we present HARIBOSS++, an updated and next-generation platform designed to facilitate the study of future RNA-targeted drugs","content_hash":null,"source_reliability_class":"medium","is_primary_source":true,"is_independent":true,"is_peer_reviewed":false,"archived_url":null,"created_at":"2026-09-14T05:00:49.239Z"}],"claims":[{"id":"28fb6d8b-d480-4782-90aa-b2537c42a220","event_id":"ca036c71-9172-40fd-8adc-c2355e9133e0","claim_text":"\n\nHARIBOSS++: An Integrated Platform for RNA-Targeted Drug Design \n\n","claim_type":"outcome","claim_status":"supported","confidence_score":null,"created_at":"2026-09-14T05:00:49.245Z","updated_at":"2026-09-14T05:00:49.245Z"}],"revisions":[{"id":"81979fb5-36cc-4667-955d-937184490520","event_id":"ca036c71-9172-40fd-8adc-c2355e9133e0","model_id":null,"previous_score":"0.000000","new_score":"0.001000","previous_factors":{},"new_factors":{"evidence":0.1,"base_score":1,"durability":0.5,"attribution":0.1,"realization":0.2},"change_reason":"Auto-published from news ingest.","trigger_type":"news_ingest","trigger_source_ids":null,"reviewer_id":null,"review_status":"published","created_at":"2026-09-14T05:00:49.253Z"}],"secondary":[]},"methodology_version":"0.1"}